'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma.
Clicks: 241
ID: 79006
2018
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
80.4
/100
241 views
193 readers
Trending
AI Quality Assessment
Not analyzed
| Reference Key |
scott2018realworldleukemia
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Scott, Ashleigh;Weber, Nicholas;Tiley, Campbell;Taylor, Kerry;Taper, John;Harrison, Simon;Chan, Kah-Lok;Stark, Richard;Lee, Cindy;Morris, Kirk;Ho, P Joy;Dodds, Anthony;Ramanathan, Sundra;Ramakrishna, Raj;Watson, Anne-Marie;Auguston, Bradley;Kwok, Fiona;Quach, Hang;Warburton, Pauline;Rowlings, Philip;Mollee, Peter; |
| Journal | Leukemia & lymphoma |
| Year | 2018 |
| DOI | 10.1080/10428194.2017.1387911 |
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.